Oxford Immunotec Company
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT√В¬Ѓ.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).
Funding Status:
M&A
Headquarters:
Abingdon, Oxfordshire, United Kingdom
Founded Date:
01.01.2002
Investor Type:
N/A
Investment Stage:
N/A
Technology:
Genetic Test & Molecular Diagnostics
Employee Number:
501-1000
Number Of Exists:
N/A
Estimated Revenue:
$10M to $50M
Industry:
Deep Diagnostics